ArticlePloS one2025
Biomonitoring and Health Risk Assessment of Arsenic Contamination in Drinking Water among Rural Residents in Western Tehran.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Arsenic is a widespread environmental contaminant that poses a significant threat to global health due to its toxicity and carcinogenicity. Given the high levels of arsenic found in the drinking water of western areas of Tehran, the objective of this study was to analyze levels of arsenic in multiple biological samples (blood, hair, and nails) collected from residents living in these areas. This cross-sectional study was conducted over three weeks in November 2022 in five villages. A total of 67 residents from these villages were included in the exposure group. Analysis of arsenic was carried out by using the Perkin Elmer Optima 8000 ICP-OES instrument coupled with the FIAS 100 flow injection module after sample digestion. The average concentration of arsenic in people's blood was 4.19 μg/l, which exceeds the standard limit of ATSDR (1 μg/l) by about 4 times. Additionally, 47.8% of blood samples exceeded the standard, while for nail and hair samples, the percentages were 22.4% and 13.4%, respectively. Water samples showed the highest percentage above the standard, with 67.2%. There is no significant relationship between arsenic levels in drinking water, hair and blood. However, a significant positive correlation was observed between the concentration of arsenic in drinking water and nail samples. The mean of hazard quotient (HQ) and carcinogenic risk (CR) indices of arsenic in drinking water suggest that the daily intake levels of the examined arsenic in the study area exceeded the acceptable thresholds ((HQ < 1) and (CR < 1 × 10-4)). Although this study demonstrated elevated arsenic exposure among the population in western Tehran, our findings showed no significant correlation between arsenic concentrations in drinking water and biological samples. Therefore, further research is required to identify other potential exposure pathways and develop targeted intervention strategies. Additionally, remediation measures to improve water quality remain essential in this rural area.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.